Search Results - "KILGORE, Michael W"

Refine Results
  1. 1

    Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner by Al-Alem, Linah, Southard, R Chase, Kilgore, Michael W, Curry, Thomas E

    Published in PloS one (21-01-2011)
    “…Peroxisome Proliferator Activated Receptor gamma (PPARγ) agonists, such as the thiazolinediones (TZDs), have been studied for their potential use as cancer…”
    Get full text
    Journal Article
  2. 2

    Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells by Wang, Xin, Kilgore, Michael W.

    Published in Molecular and cellular endocrinology (30-08-2002)
    “…We have previously demonstrated that peroxisome proliferator-activated receptor gamma (PPARγ) is expressed and transcriptionally responsive to both synthetic…”
    Get full text
    Journal Article
  3. 3

    Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells by Zaytseva, Yekaterina Y, Wang, Xin, Southard, R Chase, Wallis, Natalie K, Kilgore, Michael W

    Published in Molecular cancer (05-12-2008)
    “…Peroxisome proliferator-activated receptor gamma (PPARgamma) is a member of the nuclear hormone receptor superfamily and is highly expressed in many human…”
    Get full text
    Journal Article
  4. 4

    Activation of the PKC Pathway Stimulates Ovarian Cancer Cell Proliferation, Migration, and Expression of MMP7 and MMP10 by AL-ALEM, Linah F, MCCORD, Lauren A, SOUTHARD, R. Chase, KILGORE, Michael W, CURRY, Thomas E

    Published in Biology of reproduction (01-09-2013)
    “…Postmenopausal women are at a higher risk of ovarian cancer due, in part, to increased levels of gonadotropins such as luteinizing hormone (LH). Gonadotropins…”
    Get full text
    Journal Article
  5. 5

    Distinct modulation of voltage‐gated and ligand‐gated Ca2+ currents by PPAR‐γ agonists in cultured hippocampal neurons by Pancani, Tristano, Phelps, Jeremiah T., Searcy, James L., Kilgore, Michael W., Chen, Kuey‐Chu, Porter, Nada M., Thibault, Olivier

    Published in Journal of neurochemistry (01-06-2009)
    “…Type 2 diabetes mellitus is a metabolic disorder characterized by hyperglycemia and is especially prevalent in the elderly. Because aging is a risk factor for…”
    Get full text
    Journal Article
  6. 6

    Oxa-Enediynes:  Probing the Electronic and Stereoelectronic Contributions to the Bergman Cycloaromatization by Jones, Graham B, Wright, Justin M, Hynd, George, Wyatt, Justin K, Warner, Philip M, Huber, Robert S, Li, Aiwen, Kilgore, Michael W, Sticca, Robert P, Pollenz, Richard S

    Published in Journal of organic chemistry (09-08-2002)
    “…Efficient routes to three classes of 10-membered oxa-enediynes are presented. The electronic and stereoelectronic contributions to half-lives are supported by…”
    Get full text
    Journal Article
  7. 7

    MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response by Kilgore, Michael W, Tate, Patricia L, Rai, Sudha, Sengoku, Eiichi, Price, Thomas M

    Published in Molecular and cellular endocrinology (16-05-1997)
    “…Peroxisome proliferator-activated receptors (PPARs) are ligand-activated nuclear receptors that regulate transcription of target genes. Since attempts have…”
    Get full text
    Journal Article
  8. 8

    Activation of the PKC Pathway Stimulates Ovarian Cancer Cell Proliferation, Migration, and Expression of MMP7 and MMP101 by Al-Alem, Linah F, McCord, Lauren A, Southard, R. Chase, Kilgore, Michael W, Curry, Thomas E

    Published in Biology of reproduction (01-09-2013)
    “…Postmenopausal women are at a higher risk of ovarian cancer due, in part, to increased levels of gonadotropins such as luteinizing hormone (LH). Gonadotropins…”
    Get full text
    Journal Article
  9. 9

    MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells by Wang, Xin, Southard, R. Chase, Allred, Clinton D., Talbert, Dominique R., Wilson, Melinda E., Kilgore, Michael W.

    Published in Breast cancer research and treatment (01-09-2008)
    “…The peroxisome proliferator-activated receptor gamma 1 (PPARγ1) is a nuclear receptor that plays a pivotal role in breast cancer and is highly over-expressed…”
    Get full text
    Journal Article
  10. 10

    The Increased Expression of Peroxisome Proliferator-Activated Receptor-γ1 in Human Breast Cancer Is Mediated by Selective Promoter Usage by Wang, Xin, Southard, R. Chase, Kilgore, Michael W.

    Published in Cancer research (Chicago, Ill.) (15-08-2004)
    “…Peroxisome proliferator-activated receptor-γ1 (PPARγ1) is transactivated by a wide range of ligands in normal human mammary epithelial and breast cancer cells…”
    Get full text
    Journal Article
  11. 11

    Ad4BP/SF-1 Regulates Cyclic AMP-induced Transcription from the Proximal Promoter (PII) of the Human Aromatase P450 (CYP19) Gene in the Ovary by Michael, M. Dodson, Kilgore, Michael W., Morohashi, Ken-ichirou, Simpson, Evan R.

    Published in The Journal of biological chemistry (02-06-1995)
    “…Aromatase P450, which is responsible for the metabolism of C19 steroids to estrogens, is expressed in the pre-ovulatory follicles and corpora lutea of…”
    Get full text
    Journal Article
  12. 12

    Target-Directed Enediynes:  Designed Estramycins by Jones, Graham B, Hynd, George, Wright, Justin M, Purohit, Ajay, Plourde, Gary W, Huber, Robert S, Mathews, Jude E, Li, Aiwen, Kilgore, Michael W, Bubley, Glenn J, Yancisin, Molly, Brown, Myles A

    Published in Journal of organic chemistry (01-06-2001)
    “…The goal of selective targeting of enediyne cytotoxins has been investigated using estrogenic delivery vehicles. A series of estrogen−enediyne conjugates were…”
    Get full text
    Journal Article
  13. 13

    Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues by Means, G D, Kilgore, M W, Mahendroo, M S, Mendelson, C R, Simpson, E R

    Published in Molecular endocrinology (Baltimore, Md.) (01-12-1991)
    “…The formation of estrogens from C19 steroids is catalyzed by a specific form of cytochrome P450, aromatase cytochrome P450 (P450AROM; the product of the CYP19…”
    Get more information
    Journal Article
  14. 14

    Selective activation of PPARγ in breast, colon, and lung cancer cell lines by Allred, Clinton D., Kilgore, Michael W.

    Published in Molecular and cellular endocrinology (12-05-2005)
    “…Peroxisome proliferator-activated receptor gamma (PPARγ) plays a critical albeit poorly defined role in the development and progression of several cancer types…”
    Get full text
    Journal Article
  15. 15

    Transactivation of ERα by Rosiglitazone induces proliferation in breast cancer cells by Talbert, Dominique R., Allred, Clinton D., Zaytseva, Yekaterina Y., Kilgore, Michael W.

    Published in Breast cancer research and treatment (01-03-2008)
    “…In the present study, we demonstrate that Rosiglitazone (Rosi), a thiazolidinedione and PPARγ agonist, induces ERE (Estrogen Receptor Response Element)…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Specific Thiazolidinediones Inhibit Ovarian Cancer Cell Line Proliferation and Cause Cell Cycle Arrest in a PPAR[gamma] Independent Manner by Al-Alem, Linah, Southard, R. Chase, Kilgore, Michael W, Curry, Thomas E

    Published in PloS one (21-01-2011)
    “…Background Peroxisome Proliferator Activated Receptor gamma (PPAR[gamma]) agonists, such as the thiazolinediones (TZDs), have been studied for their potential…”
    Get full text
    Journal Article
  18. 18

    Abstract 1723: Thiazolinediones (TZDs) mediate proliferation and cell cycle kinetics in ovarian cancer cells in a PPARγ-dependent and -independent manner by Al-Alem, Linah F., Southard, Chase R., Kilgore, Michael W., Curry, Thomas E.

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Ovarian cancer is the leading cause of death in women with gynecological malignancies and is often called the ‘silent killer’. Thus, new treatment targets are…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Initial characterization of a subclone of the MA-10 mouse Leydig tumor cell line by Kilgore, M W, Stocco, D M

    Published in Endocrinology (Philadelphia) (01-03-1989)
    “…Cloned cell lines have proven to be useful models in understanding the regulation of endocrine cells and steroid synthesis. In this study we report the…”
    Get more information
    Journal Article